Observatory · observe first
Follow the allocation change
Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.
Historical time machine
Historical observation
20182026
1 · Sector
Weight and 12M allocation change
2 · Industry
Inside Health Care
Pharmaceuticals4.68%+4.67 ppHealth Care Equipment3.16%+3.15 ppBiotechnology2.12%+2.12 ppLife Sciences Tools & Services2.11%+2.11 ppManaged Health Care2.02%+2.01 ppHealth Care Services0.86%+0.86 ppHealth Care Distributors0.29%+0.28 ppHealth Care Supplies0.28%+0.28 ppHealth Care Facilities0.24%+0.24 ppHealth Care Technology0.00%+0.00 pp
3 · Sub-industry
Inside Biotechnology
Biotechnology · weight
2.12%
Industry change · 12M
+2.12 pp
Biotechnology · contribution
+2.117 pp
Company participation
100%
of industry constituents above their 6M weight average
4 · Companies driving this sub-industry
Jun 2021 · sorted by absolute contribution to 12-month change
| Company | Country | Market cap | Universe weight | 3M contribution | 12M contribution | 12M price return | Above 6M weight average |
|---|---|---|---|---|---|---|---|
| AbbVie → ABBV | United States | $198.9bn | 0.702% | +0.329 pp | +0.702 pp | +20.5% | Yes |
| Amgen → AMGN | United States | $140.0bn | 0.494% | +0.213 pp | +0.494 pp | +6.3% | Yes |
| Gilead Sciences → GILD | United States | $86.4bn | 0.305% | +0.146 pp | +0.304 pp | -6.5% | Yes |
| Regeneron Pharmaceuticals → REGN | United States | $52.5bn | 0.185% | +0.098 pp | +0.185 pp | -10.4% | Yes |
| Vertex Pharmaceuticals → VRTX | United States | $52.2bn | 0.184% | +0.075 pp | +0.184 pp | -30.5% | Yes |
| Biogen → BIIB | United States | $52.1bn | 0.184% | +0.101 pp | +0.184 pp | +29.4% | Yes |
| Incyte → INCY | United States | $18.5bn | 0.065% | +0.030 pp | +0.065 pp | -19.1% | Yes |
Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.